Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
34.13Price to Book
VS
Market
Sector
Industry
History
$ 4.34Close
$ 0.71 - $ 6 52-Week Range
Ticker Information
Ticker
LIXTCompany Name
LIXTE BIOTECHNOLOGY HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLIXTE BIOTECHNOLOGY HOLDINGS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LIXT - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 651.46K | $ 22.24M | 34.13 |
| 3/31/2025 | $ 1.16M | $ 3.44M | 2.96 |
| 12/31/2024 | $ 827.22K | $ 3.6M | 4.35 |
| 9/30/2024 | $ 1.37M | $ 3.78M | 2.76 |
| 6/30/2024 | $ 2.25M | $ 4.86M | 2.16 |
| 3/31/2024 | $ 3.13M | $ 6.12M | 1.96 |
| 12/31/2023 | $ 3.99M | $ 5.17M | 1.3 |
| 9/30/2023 | $ 4.92M | $ 6.37M | 1.29 |
| 6/30/2023 | $ 2.69M | $ 5.89M | 2.19 |
| 3/31/2023 | $ 4.08M | $ 10.13M | 2.48 |
Key Performance Insights, Last 5 Years
- LIXTE BIOTECHNOLOGY HOLDINGS INC's latest trailing twelve months (TTM) P/B stands at 11.17.
- Over the past 5 years, LIXTE BIOTECHNOLOGY HOLDINGS INC's average P/B has been 5.24.
- The median P/B for LIXTE BIOTECHNOLOGY HOLDINGS INC during this period was 2.86
- LIXTE BIOTECHNOLOGY HOLDINGS INC reached its highest P/B over the past 5 years at 34.13.
- The lowest P/B recorded by LIXTE BIOTECHNOLOGY HOLDINGS INC in the same timeframe 1.28
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for LIXTE BIOTECHNOLOGY HOLDINGS INC is calculated as follows: Market Cap [ $ 12.74M ] / Equity [ $ 1.14M ]
(=) P/B [ 11.17 ] LIXT - Price to Book, Last 5 years
1.28
Minimum
Sep 30, 2022
34.13
Maximum
Jun 30, 2025
5.24
Average
2.86
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |